Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction
- Z. A. Wainberg
- , L. S. Lin
- , B. Dicarlo
- , K. M. Dao
- , R. Patel
- , D. J. Park
- , H. J. Wang
- , R. Elashoff
- , N. Ryba
- , J. R. Hecht
Research output: Contribution to journal › Article › peer-review
83
Scopus
citations